NCT03490097View on ClinicalTrials.gov

Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

May 23, 2018

Study Completion Date

May 23, 2018

Conditions
Chronic Hepatitis cMetabolic Syndrome
Interventions
DRUG

Simvastatin 10mg

tablets

DRUG

sofosbuvir plus daclatasvir

sofosbuvir 400mg daclatasvir 60 mg daily for 12 weeks.

Trial Locations (1)

Unknown

Kobri El koba Armed Forces Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03490097 - Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination | Biotech Hunter | Biotech Hunter